1. P-228Tumor Treating Fields (150 kHz) combined with FOLFOX inhibits gastric cancer in vitro. (2nd July 2019) Authors: Zeevi, E; Gotlib, K; Shnaiderman, R; Munster, M; Porat, Y; Voloshin, T; Davidi, S; Shteingauz, A; Kaynan, N; Giladi, M; Kirson, E; Weinberg, U; Kinzel, A; Palti, Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P02.04 Tumor treating fields induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. (19th September 2018) Authors: Voloshin, T; David, S; Porat, Y; Shteingauz, A; Munster, M; Kaynan, N; Giladi, M; Kirson, E; Weinberg, U; Palti, Y Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P02.04 Tumor treating fields induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. (19th September 2018) Authors: Voloshin, T; David, S; Porat, Y; Shteingauz, A; Munster, M; Kaynan, N; Giladi, M; Kirson, E; Weinberg, U; Palti, Y Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗